核心观点 - 全球医疗机器人与智能外科大奖（MedRobot Awards 2025）旨在表彰和推动中国智能医疗产业的关键贡献者，涵盖整机厂商、供应链企业、服务机构及个人[1] - 手术机器人被视为未来十年医疗科技最具爆发力的领域，奖项聚焦技术进步、临床转化与产业协同[1] - 评奖视角从单一设备扩展到系统化能力、生态协同及产业闭环，强调术前-术中-术后全流程创新[2][3] 奖项板块与类别 一、手术机器人整机类 - **年度手术机器人奖**：从获奖企业中提名，不开放自主申报[4] - **产业引领奖**：针对已获批上市且具备装机规模的整机企业，要求截至2024年底完成产品注册并推动市场教育[5] - **技术创新奖**：表彰在系统架构、算法、术式支持或核心部件等方面有突破性成果的企业[6] - **临床创新奖**：鼓励多学科或新兴科室的创新术式案例，需联合医疗机构申报[7] - **市场表现奖**：要求近一年完成关键里程碑、装机量显著增长或打开新科室，市场影响广泛[8][9][10] - **国际拓展奖**：认可成功出口海外或开展国际合作的整机企业[11] 二、供应链与服务机构 - **卓越供应链奖**：表彰提供稳定、规模化交付的核心零部件或整机解决方案的企业[12][16] - **卓越服务伙伴奖**：针对支撑研发验证的专业机构，评估转化效率与资源整合能力[13][16] 三、智能外科类 - **系统创新奖**：覆盖术前规划、术中导航、术后随访的数字化能力，需具备智能控制与个性化规划[14][15][17] - **合作典范奖**：奖励推动智能外科系统建设的医院或医工联合团队，要求实际优化术式或患者获益[18][21] 四、医疗服务机器人类 - **年度康复机器人奖**：聚焦运动/神经康复领域，评估产品设计、患者依从性及医院部署数量[19][22] - **年度医疗服务机器人奖**：针对病房/ICU的护理、消杀机器人，考核使用频次与系统集成能力[19][22] 五、个人奖项 - **年度医生（团队）奖**：表彰主导临床验证、术式共研的医生团队，需具备科研成果与行业影响力[20][27] - **年度企业家奖**：奖励推动商业化突破的创业者，评估公司成长性及技术前瞻性[23][27] - **创新转化奖**：认可将原创技术产业化的科研团队，要求知识产权布局清晰且合作项目落地[23][27] 申报与评选流程 - 申报时间：即日起至2025年7月28日，同一主体最多申报3个奖项[24][25][28] - 评选机制：专家评审+行业提名+部分大众投票，获奖企业将获颁奖典礼参与权及媒体曝光[26][28][29] - 颁奖时间：2025年9月5日，同步发布中英文获奖名单[30][31]

SAN DIEGO, July 22, 2025 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that the RxSight class action lawsuit – captioned Makaveev v. RxSight, Inc., No. 25-cv-01596 (C.D. Cal.) – seeks to represent purchasers or acquirers of RxSight, Inc. (NASDAQ: RXST) securities and charges certain of RxSight’s top executives with violations of the Securities Exchange Act of 1934. If you suffered substantial losses and wish to serve as lead plaintiff of the RXSight class action lawsuit, please provide your ...

In the latest close session, Doximity (DOCS) was down 1.44% at $59.38. The stock's change was less than the S&P 500's daily gain of 0.06%. Meanwhile, the Dow gained 0.41%, and the Nasdaq, a tech-heavy index, lost 0.39%. The stock of medical social networking site has risen by 3.92% in the past month, leading the Medical sector's loss of 1.83% and undershooting the S&P 500's gain of 5.88%.The investment community will be paying close attention to the earnings performance of Doximity in its upcoming release. ...

财务表现 - 公司2025年第二季度营收达24 4亿美元 同比增长21 4% [1] - 每股收益(EPS)为2 19美元 较去年同期的1 78美元增长23% [1] - 营收超出Zacks一致预期2 35亿美元 超预期3 93% [1] - EPS超出分析师预期的1 92美元 超预期14 06% [1] 业务细分 - 产品收入(仪器配件及系统)达20 5亿美元 同比增长21% 超分析师平均预期1 96亿美元 [4] - 服务收入达3 912亿美元 同比增长23 3% 超分析师平均预期3 6886亿美元 [4] - 系统收入达5 747亿美元 同比增长28 2% 超分析师平均预期5 1621亿美元 [4] - 仪器及配件收入达14 7亿美元 同比增长18 5% 超分析师平均预期14 4亿美元 [4] 运营指标 - 达芬奇手术系统装机量达10,488台 超四位分析师平均预期的10,427台 [4] 市场表现 - 公司股价过去一个月上涨0 2% 同期标普500指数上涨5 9% [3] - 公司当前Zacks评级为2级(买入) 预示短期内可能跑赢大盘 [3]

Bristol Myers Squibb (BMY) ended the recent trading session at $48.02, demonstrating a +2.85% change from the preceding day's closing price. The stock outperformed the S&P 500, which registered a daily gain of 0.06%. On the other hand, the Dow registered a gain of 0.41%, and the technology-centric Nasdaq decreased by 0.39%. The stock of biopharmaceutical company has fallen by 0.49% in the past month, leading the Medical sector's loss of 1.83% and undershooting the S&P 500's gain of 5.88%.The investment comm ...

Hologic (HOLX) closed at $65.37 in the latest trading session, marking a +2.64% move from the prior day. The stock outpaced the S&P 500's daily gain of 0.06%. Meanwhile, the Dow experienced a rise of 0.41%, and the technology-dominated Nasdaq saw a decrease of 0.39%. The medical device maker's shares have seen a decrease of 1.15% over the last month, surpassing the Medical sector's loss of 1.83% and falling behind the S&P 500's gain of 5.88%.The investment community will be paying close attention to the ear ...

Largest commercial insurer in the United States releases positive comprehensive coverage for AI-enabled Heartflow Plaque Analysis to support precise diagnosis and management of patientsMOUNTAIN VIEW, Calif., July 22, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc., the leader in AI technology for coronary artery disease (CAD), today announced Heartflow Plaque Analysis will be covered by UnitedHealthcare across all lines of business, including Commercial, Medicare Advantage, and Community plans. UnitedHealthcare is ...

USANA Health Sciences (USNA) came out with quarterly earnings of $0.74 per share, beating the Zacks Consensus Estimate of $0.54 per share. This compares to earnings of $0.54 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +37.04%. A quarter ago, it was expected that this nutritional supplement maker would post earnings of $0.7 per share when it actually produced earnings of $0.73, delivering a surprise of +4.29%.Over the last ...

Intuitive Surgical, Inc. (ISRG) came out with quarterly earnings of $2.19 per share, beating the Zacks Consensus Estimate of $1.92 per share. This compares to earnings of $1.78 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +14.06%. A quarter ago, it was expected that this company would post earnings of $1.71 per share when it actually produced earnings of $1.81, delivering a surprise of +5.85%.Over the last four quarters, th ...

该公司将通过IPO募资1.005亿美元。 面相脊柱的人工智能（AI）手术公司Carlsmed将美国IPO股票的发行价定在每股15美元，位于发行价指 导区间的中部。 ...